Hypogonadism Completed Phase 2 Trials for Testosterone enanthate (DB13944)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02697188Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal MenTreatment
NCT02777242Safety of Subcutaneous Testosterone Enanthate in Adult Male HypogonadismTreatment
NCT00695110Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal MenTreatment